Bluejay Diagnostics Inc (BJDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,302 | 5,756 | 8,058 | 2,661 | 2,209 |
| Other current assets | 0 | 0 | 0 | 0 | 265 |
| TOTAL | $4,899 | $6,568 | $9,018 | $3,450 | $3,221 |
| Non-Current Assets | |||||
| PPE Net | 1,514 | 1,535 | 1,553 | 1,302 | 1,286 |
| Other Non-Current Assets | 245 | 251 | 288 | 324 | 362 |
| TOTAL | $1,759 | $1,786 | $1,841 | $1,625 | $1,648 |
| Total Assets | $6,657 | $8,353 | $10,859 | $5,075 | $4,869 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 145 | 317 | 490 | 272 | 492 |
| Accrued Expenses | 552 | 621 | 1,291 | 1,108 | 1,117 |
| TOTAL | $810 | $1,049 | $2,057 | $1,526 | $1,771 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 118 | 140 | 161 | 182 | 202 |
| TOTAL | $118 | $140 | $161 | $182 | $202 |
| Total Liabilities | $928 | $1,189 | $2,218 | $1,708 | $1,974 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 139 | 134 | 31 | 2 | 2 |
| Common Shares | 0 | 2 | 0 | 0 | N/A |
| Retained earnings | -34,669 | -33,237 | -31,755 | -29,280 | -26,951 |
| TOTAL | $5,730 | $7,164 | $8,641 | $3,367 | $2,895 |
| Total Liabilities And Equity | $6,657 | $8,353 | $10,859 | $5,075 | $4,869 |